Alvotech and Teva Pharmaceuticals announced the US Food and Drug Administration (FDA) has accepted for review a Biologics ...

We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...

The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.

The key to efficient pharma, manufacturing productionBy Anton Oosthiuizen, Commercial Director, QuickEasy SoftwareIssued by QuickEasy SoftwareJohannesburg, 18 Feb 2025Visit our press officeDon't let ...